Reschedules Q3 results conference call to
11:30 am EST on November 15, 2023
PLEASANTON, Calif., Nov. 14,
2023 /PRNewswire/ -- Movano Inc.
(NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare
solutions company at the intersection of medtech and consumer
devices and makers of the Evie Ring,
today announced that, in light of the Company's recently announced
proposed common stock offering, Movano Health has issued its Form
10-Q for the third quarter of 2023 and will report third quarter
2023 financial and operating results on Wednesday, November
15, 2023, before the equity markets open. Management will host a
conference call and live audio webcast to discuss these results and
provide a business update at 8:30 a.m. PST (11:30 a.m. EST).
Attendees can access the live webcast here or on the
investors section of Movano Health's website at
https://ir.movano.com. The conference call can be accessed by
dialing 1-877-407-0989 (domestic) or +1- 201-389-0921
(international). Attendees can also use the Call Me Link, in
which they will be dialed in to the conference call instantly on
the number provided with no hold time. An archived webcast will be
available on Movano Health's website approximately one hour after
the completion of the event and for two years thereafter.
About Movano Health
Founded in 2018, Movano Inc. (Nasdaq: MOVE) dba Movano Health
is developing a suite of purpose-driven healthcare solutions to
bring medical-grade, high-quality data to the forefront of consumer
health devices. Featuring modern form factors, Movano Health's
devices capture a comprehensive picture of a person's vital health
information and uniquely translate the data into personalized and
intelligent insights that empower consumers to live healthier and
more balanced lives. Movano Health's end-to-end solutions will soon
enable consumers and their healthcare professionals to utilize
daily medical-grade data as a tool to proactively monitor and
manage health outcomes. For more information on Movano
Health, visit https://movanohealth.com/.
Forward Looking Statements
This press release contains forward-looking statements
concerning our expectations, anticipations, intentions, beliefs, or
strategies regarding the future. These forward-looking statements
are based on assumptions that we have made as of the date hereof
and are subject to known and unknown risks and uncertainties that
could cause actual results, conditions, and events to differ
materially from those anticipated. Therefore, you should not place
undue reliance on forward-looking statements. Examples of
forward-looking statements include, among others, statements we
make regarding plans with respect to commercial launch of the Evie
Ring, anticipated FDA clearance for the Evie Ring and other
products in development, expected future operating results; product
development and features, product releases, clinical trial, and
regulatory initiatives; our strategies, positioning and
expectations for future events or performance. Important factors
that could cause actual results to differ materially from those in
the forward-looking statements are set forth in our most recent
Annual Report on Form 10-K and any subsequent Quarterly Reports on
Form 10-Q, and in our other reports filed with the Securities and
Exchange Commission, including under the caption "Risk
Factors." Any forward-looking statement in this release
speaks only as of the date of this release. We undertake no
obligation to publicly update any forward-looking statement,
whether written or oral, that may be made from time to time,
whether as a result of new information, future developments or
otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/movano-inc-to-report-third-quarter-2023-financial-results-on-wednesday-november-15-2023-301988099.html
SOURCE Movano